Universal Health Realty: FFO May Reach $3.60/Share In 2026

Universal Health Realty (UHT), a healthcare REIT, reported weaker Q2 2025 FFO, primarily due to increased taxes and interest expenses, placing it on track for the lower end of its $3.45-$3.55/share FFO outlook for 2025. Despite this, the company maintains a Buy rating, trading at an undemanding 11.3x FFO multiple, as FFO growth is projected for 2026 driven by anticipated Fed rate cuts and stronger revenues. Key risks to the investment case include UHT's 40% revenue exposure to Universal Health Services and the potential for slower-than-expected Fed rate reductions.

Analysis

Universal Health Realty (UHT) reported a weaker Q2 2025 performance, with Funds From Operations (FFO) being negatively impacted by rising taxes and interest expenses. This near-term headwind positions the healthcare REIT to achieve the lower end of its full-year 2025 FFO guidance of $3.45-$3.55 per share. Despite this, the outlook remains positive, underscored by a maintained "Buy" rating and a prospective FFO recovery in 2026, which is predicated on anticipated Federal Reserve rate cuts and revenue strengthening. The company's valuation appears favorable at an 11.3x FFO multiple, particularly as its stock has delivered a ~13% gain year-to-date, outperforming the Vanguard Real Estate Index Fund ETF (VNQ). However, two significant risks temper the outlook: a high tenant concentration, with 40% of revenue derived from Universal Health Services (UHS), and the macroeconomic uncertainty surrounding the timing and magnitude of Fed rate cuts.

Key Decisions for Investors

• Given the undemanding 11.3x FFO multiple and projected FFO growth in 2026, investors might consider the current share price an attractive entry point, in line with the article's buy thesis.
• Investors must closely monitor the financial stability of Universal Health Services (UHS), as UHT's 40% revenue concentration represents a significant single-tenant risk to its cash flows.
• The positive outlook is highly dependent on future monetary policy, so it is critical to track Federal Reserve guidance, as any delay in rate cuts could postpone the expected 2026 FFO recovery and temper stock performance.